Now Accepting Medicaid At All Locations!
Our Office
Visit Us Online
Now Accepting Medicaid At All Locations!
Oral cancer remains a significant health concern, but outcomes improve dramatically when the disease is found early. Detecting suspicious changes in the mouth at an early stage can raise survival rates and expand treatment options. For patients, that means routine screenings are not an optional extra — they are an important preventive step that can catch problems before they progress.
Many common risk factors are well known: tobacco use, heavy alcohol consumption, and certain strains of human papillomavirus (HPV) increase risk. That said, oral cancers can and do occur in people without obvious risk factors, which is why visual and adjunctive screening tools are valuable for broad, inclusive care.
Screening isn’t designed to alarm; it’s designed to provide information. The goal is to give patients a clearer, evidence‑based assessment of soft tissue health and, when needed, a practical plan for follow‑up. Regular exams create a baseline so changes can be noticed sooner rather than later.
VELscope® is a handheld screening device that uses a specific wavelength of blue light to make natural tissue fluorescence visible. Healthy oral mucosa emits a characteristic glow under that light, while abnormal tissue often shows a different fluorescence pattern. This contrast helps clinicians identify areas that merit a closer look.
Because VELscope® highlights biochemical and structural alterations in soft tissue, it can reveal lesions that may be difficult to see during a conventional white‑light exam. It is noninvasive, quick, and painless — making it an ideal adjunct for routine screenings during hygiene appointments or comprehensive checkups.
Importantly, VELscope® is an aid, not a definitive test. It expands the clinician’s ability to detect suspicious patterns but does not replace clinical judgment, palpation, or diagnostic procedures like biopsy when indicated. Used responsibly, it strengthens early‑detection efforts without adding complexity to the patient experience.
A VELscope® exam is simple and straightforward. During a routine visit, your clinician will dim the lights and use the handheld device to scan the inside of the mouth, including the tongue, floor of mouth, inner cheeks, and soft palate. The process is brief — usually only a few minutes — and causes no discomfort.
Before the exam, there is no special preparation required. Patients can eat, drink, and continue their normal oral hygiene routines. The clinician will compare the observed fluorescence patterns to what is expected for healthy tissue and will also perform a visual inspection and gentle palpation of any areas of concern.
Findings from the VELscope® exam are documented in the patient record so changes can be tracked over time. If an unusual area is detected, your provider will explain what was seen, answer questions, and discuss appropriate next steps — whether that means watchful monitoring, targeted imaging, or referral for further evaluation.
A VELscope® result that shows altered fluorescence does not automatically indicate cancer. Many benign conditions — including trauma, inflammation, and reactive lesions — can alter tissue fluorescence. Because of this, suspicious findings prompt additional clinical assessment rather than immediate conclusions.
When a persistent or concerning lesion is identified, the usual pathway includes closer visual and tactile examination, a review of medical and dental history, and, if necessary, referral to a specialist for biopsy or advanced diagnostic testing. Timely coordination between your dental provider and medical colleagues helps ensure efficient and appropriate care.
For patients, the practical takeaway is straightforward: detection leads to options. Whether an area turns out to be benign or requires treatment, identifying it early broadens the choices available and supports more conservative, effective management when appropriate.
Oral cancer screening is most effective when it’s part of a comprehensive approach to oral wellness. That means combining advances like VELscope® with routine exams, professional cleanings, and patient education about risk factors and warning signs. Together, these components build a reliable system for prevention and early detection.
Patients can play an active role by maintaining regular dental visits, reporting any persistent mouth changes (sore spots, lumps, unexplained numbness, or nonhealing ulcers), and discussing lifestyle factors that may affect risk. Small changes in habits and close communication with your dental team add meaningful protection over time.
At New Day Dentistry, we integrate VELscope® screening into our standard evaluations to complement our clinical exam and give patients a clearer picture of oral soft tissue health. Our objective is to provide thoughtful, evidence‑based screening that supports informed decisions and timely follow‑up when needed.
Advanced, noninvasive tools like VELscope® strengthen traditional oral exams by making subtle tissue changes more apparent. While it is not a standalone diagnostic test, when used alongside clinical evaluation it improves the ability to detect areas that warrant closer attention and potential intervention.
If you value prevention and early detection, ask about VELscope® screening at your next dental visit. Our team is committed to clear communication, careful documentation, and coordinated care when additional evaluation is needed. Contact us to learn more about this screening and how it fits into a comprehensive oral‑health plan.
VELscope® cancer screening is an adjunctive oral soft tissue examination that uses a specific wavelength of blue light to help reveal changes in tissue fluorescence. It is designed to assist clinicians in visualizing biochemical and structural alterations that may not be obvious under standard white light. The device itself is handheld, noninvasive, and intended to supplement—not replace—clinical inspection and palpation.
The purpose of the screening is early detection, which can expand diagnostic options and improve outcomes when abnormalities are identified promptly. Results are interpreted in the context of the full oral exam and patient history to guide appropriate follow-up. When indicated, further evaluation such as targeted imaging or referral for biopsy may be recommended.
VELscope® emits a narrow-band blue light that excites natural fluorophores in healthy oral mucosa, producing a characteristic fluorescence pattern. Abnormal tissue frequently demonstrates a loss or alteration of that fluorescence, appearing as dark or differently colored areas against the normal glow. This contrast helps clinicians pinpoint regions that merit closer inspection or documentation.
The device highlights biochemical and structural changes rather than diagnosing specific conditions, so observed differences prompt clinical correlation rather than immediate conclusions. Clinicians combine VELscope® findings with visual assessment, palpation, and the patient’s medical and dental history to determine next steps. In many cases, serial exams and photographic documentation help track whether an area changes over time.
Routine oral cancer screenings improve the likelihood of detecting lesions at an earlier, more treatable stage, which can positively affect prognosis and available treatment options. Many oral cancers are more manageable when found early, and early detection often allows for less extensive treatment and better functional outcomes. Regular screenings also establish a baseline so changes can be recognized more readily on subsequent visits.
Screenings are valuable for all patients because oral cancers can occur with or without classic risk factors such as tobacco, alcohol, or HPV exposure. Including adjunctive tools like VELscope® broadens the clinician’s ability to identify subtle abnormalities across a wider patient population. Patient awareness and prompt reporting of persistent oral changes further strengthen early-detection efforts.
During a routine visit the clinician will dim the lights and use the handheld VELscope® device to scan the oral tissues, including the tongue, floor of mouth, inner cheeks, and soft palate. The scan typically takes only a few minutes and is painless; clinicians will also perform a visual exam and gentle palpation of any areas that appear unusual. Findings are recorded in the patient record so changes can be monitored over time.
If an area shows altered fluorescence, the clinician will explain what was observed, review relevant history and symptoms, and discuss appropriate next steps such as watchful monitoring, additional imaging, or referral for specialist evaluation. The goal is to provide clear information and a practical follow-up plan rather than to cause alarm. At New Day Dentistry we document findings carefully to support continuity of care and timely reassessment when needed.
Yes. VELscope® screening is noninvasive and causes no discomfort; the device simply emits a specific wavelength of light and requires no contact beyond standard intraoral scanning. There is no radiation exposure, and the procedure does not require special preparation, allowing patients to eat, drink, and continue normal oral hygiene before the visit. The brief nature of the exam makes it suitable to include in routine hygiene appointments or comprehensive checkups.
Because the tool is adjunctive, clinicians rely on it alongside clinical skills rather than as a standalone test, minimizing the likelihood of unnecessary procedures based solely on fluorescence differences. Any suspicious findings are handled through established diagnostic pathways to ensure patient safety and appropriate care. Patients are encouraged to ask questions about what was seen and the rationale for recommended next steps.
VELscope® is effective at highlighting areas of altered tissue fluorescence that may indicate a range of underlying conditions, including early dysplastic changes, mucosal inflammation, reactive lesions, or areas of healing or trauma. It can reveal changes that are not easily visible under normal lighting by making biochemical and structural differences more apparent. However, altered fluorescence is not specific to malignant disease and must be interpreted in the clinical context.
Because many benign conditions can affect fluorescence, clinicians use VELscope® findings as a prompt for closer examination and documentation rather than definitive diagnosis. Persistent or concerning lesions identified with VELscope® typically lead to further assessment such as biopsy or specialist referral when clinically warranted. The device helps prioritize which areas should receive timely attention.
No. VELscope® is an adjunctive screening tool that enhances visual examination but does not provide histopathologic diagnosis. Biopsy remains the gold standard for diagnosing oral cancers and precancerous conditions, and any persistent lesion with suspicious clinical features will require further diagnostic evaluation. VELscope® findings inform clinical decision-making but are not a substitute for definitive testing.
When altered fluorescence is observed, clinicians consider the full clinical picture—history, visual exam, palpation, and symptomatology—to decide whether to monitor, image, or refer for biopsy. Timely coordination with medical specialists ensures patients receive appropriate diagnostic workup when indicated. Using VELscope® responsibly helps direct resources toward lesions that need further assessment.
VELscope® screening can be beneficial for a broad range of patients, including those with known risk factors such as tobacco or heavy alcohol use, patients with persistent oral lesions or unexplained symptoms, and individuals who want a more comprehensive soft tissue assessment. Because oral cancers sometimes occur without traditional risk factors, many clinicians recommend adjunctive screening as part of routine care for adult patients. The test is quick and noninvasive, making it practical to offer widely.
Patients with new, nonhealing ulcers, lumps, oral numbness, or unexplained persistent soreness should seek evaluation promptly, and clinicians may use VELscope® as part of that assessment. Shared decision-making between clinician and patient helps determine the role of adjunctive screening based on individual risk, history, and clinical findings. Regular dental visits remain a critical opportunity for early detection.
Oral cancer screening frequency is typically aligned with routine dental visits, which for most patients occur every six months as part of preventive care and hygiene appointments. Clinicians may recommend more frequent monitoring for patients with higher risk profiles, a history of suspicious lesions, or recent changes that warrant closer follow-up. Establishing a consistent schedule helps create a baseline and makes it easier to detect subtle changes over time.
Decisions about screening intervals also consider individual health history, lifestyle factors, and findings from prior exams. If a clinician documents an area of concern, they will advise an appropriate timetable for reassessment or further evaluation. Maintaining regular visits and promptly reporting oral changes between appointments supports effective early-detection strategies.
At New Day Dentistry we use VELscope® as a complement to visual examination and palpation to strengthen our ability to identify soft tissue changes that may need follow-up. Findings are documented in the patient record, and clinicians combine fluorescence observations with medical and dental history to determine next steps such as watchful waiting, additional imaging, or referral for specialist evaluation. This approach emphasizes evidence‑based screening and coordinated care.
Our objective is to provide patients with clear information about what was observed and a practical plan for monitoring or further assessment when necessary. Integrating adjunctive screening into routine visits helps ensure that potential concerns are identified early and managed through appropriate clinical pathways. Patients are encouraged to discuss any symptoms or concerns with their dental team so screening can be tailored to individual needs.
